|
gptkbp:instanceOf
|
gptkb:vaccine
|
|
gptkbp:administeredBy
|
adolescents
adults
infants
healthcare workers
travelers to endemic areas
people with chronic liver disease
people at risk of exposure to blood
|
|
gptkbp:approvedBy
|
gptkb:World_Health_Organization
gptkb:U.S._Food_and_Drug_Administration
1981
|
|
gptkbp:boosterRecommended
|
not routinely
|
|
gptkbp:broadcastOn
|
0, 1, 6 months (adults)
birth, 1-2 months, 6-18 months (infants)
|
|
gptkbp:category
|
public health
immunization
essential medicine
|
|
gptkbp:contains
|
hepatitis B surface antigen
|
|
gptkbp:contraindication
|
severe allergic reaction to previous dose
|
|
gptkbp:countryOfOrigin
|
gptkb:China
gptkb:Italy
gptkb:United_States
|
|
gptkbp:discoveredBy
|
gptkb:Baruch_Blumberg
gptkb:Irving_Millman
|
|
gptkbp:immunityDuration
|
at least 20 years
|
|
gptkbp:includedIn
|
gptkb:Expanded_Programme_on_Immunization
|
|
gptkbp:marketedAs
|
gptkb:Recombivax_HB
gptkb:Engerix-B
gptkb:Heplisav-B
Twinrix (combined with hepatitis A vaccine)
|
|
gptkbp:pregnancyCategory
|
safe
|
|
gptkbp:prevention
|
gptkb:Hepatitis_B
|
|
gptkbp:routeOfAdministration
|
intramuscular injection
|
|
gptkbp:sideEffect
|
fatigue
mild fever
soreness at injection site
|
|
gptkbp:storage
|
2-8°C
|
|
gptkbp:type
|
recombinant vaccine
subunit vaccine
|
|
gptkbp:usedIn
|
healthcare worker immunization
high-risk adult immunization
universal childhood immunization
|
|
gptkbp:WHOModelListOfEssentialMedicines
|
true
|
|
gptkbp:bfsParent
|
gptkb:Hepatitis_B_surface_antigen_(Australia_antigen)
gptkb:Chiron_Corporation
|
|
gptkbp:bfsLayer
|
6
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Hepatitis B vaccine
|